Abacavir (Ziagen)

Abacavir, Platelets, and a Cardiovascular Verdict: A Top HIV Clinical Development of 2018

David Alain Wohl, M.D.

Debates about the role of abacavir (Ziagen, ABC) in the development of cardiovascular disease in persons living with HIV have raged for over a decade, and a kind of stalemate has been achieved between those who are and are not convinced of a link. Wh...

Abacavir, Platelets, and a Cardiovascular Verdict: A Top HIV Clinical Development of 2018

David Alain Wohl, M.D.

Adverse Events & Comorbidities

Reducing Risk of Myocardial Infarction in HIV-Positive People

Satyajit Das; HIV i-Base

Adverse Events & Comorbidities

This year at CROI 2018 a few studies tried to explore possible mechanisms for the association of increased myocardial infarction risk and abacavir use.

Reducing Risk of Myocardial Infarction in HIV-Positive People

Satyajit Das; HIV i-Base

This year at CROI 2018 a few studies tried to explore possible mechanisms for the association of increased myocardial infarction risk and abacavir use.

Simon Collins; HIV i-Base

Unexpected Side Effects With Generic Abacavir -- and Potential for Rare Reactions to Other Generic ARVs

Several anecdotal reports of mouth ulcers have recently been reported in people switching to generic abacavir in the UK.

Simon Collins; HIV i-Base

Unexpected Side Effects With Generic Abacavir -- and Potential for Rare Reactions to Other Generic ARVs

Several anecdotal reports of mouth ulcers have recently been reported in people switching to generic abacavir in the UK.

Theo Smart; Myles Helfand

What 2014 Development Has the Biggest Impact on HIV Care?

Each year we see new developments in HIV that improve the lives of those living with the disease and make it easier for providers to care for patients. We asked some of the leading experts what development this year they thought would have the biggest …

Theo Smart; Myles Helfand

What 2014 Development Has the Biggest Impact on HIV Care?

What's Hot in HIV Treatment

Warren Tong

Here’s a recap of the biggest developments in HIV treatment over the past year, as well as a look at what’s to come.

What's Hot in HIV Treatment

Warren Tong

Here’s a recap of the biggest developments in HIV treatment over the past year, as well as a look at what’s to come.

U.S. Food and Drug Administration

Approval of Generic Abacavir Tablets, 300 mg

1 Min Read

On June 18, 2012, FDA granted approval for a generic formulation of abacavir tablets, 300 mg, manufactured by Mylan Pharmaceuticals, indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.

FDA has determined t...

U.S. Food and Drug Administration

Approval of Generic Abacavir Tablets, 300 mg

1 Min Read

FDA has determined t...

Nelson Vergel, B.S.Ch.E., M.B.A.

FDA Report Suggests Abacavir May Not Increase Myocardial Infarction Risk After All

In a poster that was presented on March 2 at the 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011), the U.S. Food and Drug Administration (FDA) reported that it has found no evidence of an association between abacavir (ABC, Zia...

Nelson Vergel, B.S.Ch.E., M.B.A.

FDA Report Suggests Abacavir May Not Increase Myocardial Infarction Risk After All

Tenofovir Disoproxil Fumarate (Viread)

Tenofovir/Emtricitabine Performs Better Than Abacavir/Lamivudine in Subgroup of Antiretroviral-Naive, HIV-Infected Individuals

National Institute of Allergy and Infectious Diseases

Tenofovir Disoproxil Fumarate (Viread)

What

For HIV-infected individuals starting antiretroviral therapy (ART), it has been unclear which of two commonly used drug combinations is safer and more effective: abacavir plus lamivudine or tenofovir plus emtricitabine.

Now, the first publishe...

Tenofovir/Emtricitabine Performs Better Than Abacavir/Lamivudine in Subgroup of Antiretroviral-Naive, HIV-Infected Individuals

National Institute of Allergy and Infectious Diseases

What

Now, the first publishe...

Canadian AIDS Treatment Information Exchange

French Study Unexpectedly Uncovers Role of Substance Use in Heart Attacks

7 Min Read

Several years ago researchers working with a large observational database called DAD (with more than 33,000 HIV-positive people) announced that they had found a link between the use of the anti-HIV drug abacavir (Ziagen and in Kivexa, Epzicom and Tri...

Canadian AIDS Treatment Information Exchange

French Study Unexpectedly Uncovers Role of Substance Use in Heart Attacks

7 Min Read

HIV Care Cost & Access

GlaxoSmithKline Announces New Program to Provide Financial Assistance for Eligible HIV Patients in the U.S.

GlaxoSmithKline

Research Triangle Park -- GlaxoSmithKline [NYSE: GSK] announced today the launch of a new Patient Savings Card designed to help eligible patients improve compliance with their HIV regimens by reducing their out-of-pocket expenses for GSK HIV medica...

HIV Care Cost & Access

GlaxoSmithKline Announces New Program to Provide Financial Assistance for Eligible HIV Patients in the U.S.

GlaxoSmithKline